1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Oral 1.2.3 Parenteral (Subcutaneous Injection) 1.3 Market by Application 1.3.1 Global Opioid Induced Constipation Treatment Market Share by Application: 2020 VS 2026 1.3.2 Drug Store 1.3.3 Independent Pharmacies 1.3.4 Hospital Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Opioid Induced Constipation Treatment Market Perspective (2015-2026) 2.2 Global Opioid Induced Constipation Treatment Growth Trends by Regions 2.2.1 Opioid Induced Constipation Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Opioid Induced Constipation Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Opioid Induced Constipation Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Opioid Induced Constipation Treatment Players by Market Size 3.1.1 Global Top Opioid Induced Constipation Treatment Players by Revenue (2015-2020) 3.1.2 Global Opioid Induced Constipation Treatment Revenue Market Share by Players (2015-2020) 3.2 Global Opioid Induced Constipation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Opioid Induced Constipation Treatment Revenue 3.4 Global Opioid Induced Constipation Treatment Market Concentration Ratio 3.4.1 Global Opioid Induced Constipation Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Opioid Induced Constipation Treatment Revenue in 2019 3.5 Key Players Opioid Induced Constipation Treatment Area Served 3.6 Key Players Opioid Induced Constipation Treatment Product Solution and Service 3.7 Date of Enter into Opioid Induced Constipation Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Opioid Induced Constipation Treatment Breakdown Data by Type (2015-2026) 4.1 Global Opioid Induced Constipation Treatment Historic Market Size by Type (2015-2020) 4.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Type (2021-2026) 5 Opioid Induced Constipation Treatment Breakdown Data by Application (2015-2026) 5.1 Global Opioid Induced Constipation Treatment Historic Market Size by Application (2015-2020) 5.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Opioid Induced Constipation Treatment Market Size (2015-2026) 6.2 North America Opioid Induced Constipation Treatment Market Size by Type (2015-2020) 6.3 North America Opioid Induced Constipation Treatment Market Size by Application (2015-2020) 6.4 North America Opioid Induced Constipation Treatment Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Opioid Induced Constipation Treatment Market Size (2015-2026) 7.2 Europe Opioid Induced Constipation Treatment Market Size by Type (2015-2020) 7.3 Europe Opioid Induced Constipation Treatment Market Size by Application (2015-2020) 7.4 Europe Opioid Induced Constipation Treatment Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Opioid Induced Constipation Treatment Market Size (2015-2026) 8.2 China Opioid Induced Constipation Treatment Market Size by Type (2015-2020) 8.3 China Opioid Induced Constipation Treatment Market Size by Application (2015-2020) 8.4 China Opioid Induced Constipation Treatment Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Opioid Induced Constipation Treatment Market Size (2015-2026) 9.2 Japan Opioid Induced Constipation Treatment Market Size by Type (2015-2020) 9.3 Japan Opioid Induced Constipation Treatment Market Size by Application (2015-2020) 9.4 Japan Opioid Induced Constipation Treatment Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Opioid Induced Constipation Treatment Market Size (2015-2026) 10.2 Southeast Asia Opioid Induced Constipation Treatment Market Size by Type (2015-2020) 10.3 Southeast Asia Opioid Induced Constipation Treatment Market Size by Application (2015-2020) 10.4 Southeast Asia Opioid Induced Constipation Treatment Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Details 11.1.2 GlaxoSmithKline Business Overview 11.1.3 GlaxoSmithKline Opioid Induced Constipation Treatment Introduction 11.1.4 GlaxoSmithKline Revenue in Opioid Induced Constipation Treatment Business (2015-2020)) 11.1.5 GlaxoSmithKline Recent Development 11.2 AstraZeneca 11.2.1 AstraZeneca Company Details 11.2.2 AstraZeneca Business Overview 11.2.3 AstraZeneca Opioid Induced Constipation Treatment Introduction 11.2.4 AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2015-2020) 11.2.5 AstraZeneca Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Opioid Induced Constipation Treatment Introduction 11.3.4 Pfizer Revenue in Opioid Induced Constipation Treatment Business (2015-2020) 11.3.5 Pfizer Recent Development 11.4 S.L.A. Pharma 11.4.1 S.L.A. Pharma Company Details 11.4.2 S.L.A. Pharma Business Overview 11.4.3 S.L.A. Pharma Opioid Induced Constipation Treatment Introduction 11.4.4 S.L.A. Pharma Revenue in Opioid Induced Constipation Treatment Business (2015-2020) 11.4.5 S.L.A. Pharma Recent Development 11.5 AIKO Biotechnology 11.5.1 AIKO Biotechnology Company Details 11.5.2 AIKO Biotechnology Business Overview 11.5.3 AIKO Biotechnology Opioid Induced Constipation Treatment Introduction 11.5.4 AIKO Biotechnology Revenue in Opioid Induced Constipation Treatment Business (2015-2020) 11.5.5 AIKO Biotechnology Recent Development 11.6 Cubist Pharmaceuticals 11.6.1 Cubist Pharmaceuticals Company Details 11.6.2 Cubist Pharmaceuticals Business Overview 11.6.3 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Introduction 11.6.4 Cubist Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2015-2020) 11.6.5 Cubist Pharmaceuticals Recent Development 11.7 Salix Pharmaceuticals 11.7.1 Salix Pharmaceuticals Company Details 11.7.2 Salix Pharmaceuticals Business Overview 11.7.3 Salix Pharmaceuticals Opioid Induced Constipation Treatment Introduction 11.7.4 Salix Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2015-2020) 11.7.5 Salix Pharmaceuticals Recent Development 11.8 Takeda Pharmaceutical 11.8.1 Takeda Pharmaceutical Company Details 11.8.2 Takeda Pharmaceutical Business Overview 11.8.3 Takeda Pharmaceutical Opioid Induced Constipation Treatment Introduction 11.8.4 Takeda Pharmaceutical Revenue in Opioid Induced Constipation Treatment Business (2015-2020) 11.8.5 Takeda Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Oral Table 4. Key Players of Parenteral (Subcutaneous Injection) Table 5. Global Opioid Induced Constipation Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 6. Global Opioid Induced Constipation Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 7. Global Opioid Induced Constipation Treatment Market Size by Regions (2015-2020) (US$ Million) Table 8. Global Opioid Induced Constipation Treatment Market Share by Regions (2015-2020) Table 9. Global Opioid Induced Constipation Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 10. Global Opioid Induced Constipation Treatment Market Share by Regions (2021-2026) Table 11. Opioid Induced Constipation Treatment Market Market Trends Table 12. Opioid Induced Constipation Treatment Market Drivers Table 13. Opioid Induced Constipation Treatment Market Challenges Table 14. Opioid Induced Constipation Treatment Market Restraints Table 15. Global Opioid Induced Constipation Treatment Revenue by Players (2015-2020) (US$ Million) Table 16. Global Opioid Induced Constipation Treatment Market Share by Players (2015-2020) Table 17. Global Top Opioid Induced Constipation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation Treatment as of 2019) Table 18. Global Opioid Induced Constipation Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Opioid Induced Constipation Treatment Product Solution and Service Table 21. Mergers & Acquisitions, Expansion Plans Table 22. Global Opioid Induced Constipation Treatment Market Size by Type (2015-2020) (US$ Million) Table 23. Global Opioid Induced Constipation Treatment Market Size Share by Type (2015-2020) Table 24. Global Opioid Induced Constipation Treatment Revenue Market Share by Type (2021-2026) Table 25. Global Opioid Induced Constipation Treatment Market Size Share by Application (2015-2020) Table 26. Global Opioid Induced Constipation Treatment Market Size by Application (2015-2020) (US$ Million) Table 27. Global Opioid Induced Constipation Treatment Market Size Share by Application (2021-2026) Table 28. North America Opioid Induced Constipation Treatment Market Size by Type (2015-2020) (US$ Million) Table 29. North America Opioid Induced Constipation Treatment Market Share by Type (2015-2020) Table 30. North America Opioid Induced Constipation Treatment Market Size by Application (2015-2020) (US$ Million) Table 31. North America Opioid Induced Constipation Treatment Market Share by Application (2015-2020) Table 32. North America Opioid Induced Constipation Treatment Market Size by Country (US$ Million) (2015-2020) Table 33. North America Opioid Induced Constipation Treatment Market Share by Country (2015-2020) Table 34. Europe Opioid Induced Constipation Treatment Market Size by Type (2015-2020) (US$ Million) Table 35. Europe Opioid Induced Constipation Treatment Market Share by Type (2015-2020) Table 36. Europe Opioid Induced Constipation Treatment Market Size by Application (2015-2020) (US$ Million) Table 37. Europe Opioid Induced Constipation Treatment Market Share by Application (2015-2020) Table 38. Europe Opioid Induced Constipation Treatment Market Size by Country (US$ Million) (2015-2020) Table 39. Europe Opioid Induced Constipation Treatment Market Share by Country (2015-2020) Table 40. China Opioid Induced Constipation Treatment Market Size by Type (2015-2020) (US$ Million) Table 41. China Opioid Induced Constipation Treatment Market Share by Type (2015-2020) Table 42. China Opioid Induced Constipation Treatment Market Size by Application (2015-2020) (US$ Million) Table 43. China Opioid Induced Constipation Treatment Market Share by Application (2015-2020) Table 44. China Opioid Induced Constipation Treatment Market Size by Region (US$ Million) (2015-2020) Table 45. China Opioid Induced Constipation Treatment Market Share by Region (2015-2020) Table 46. Japan Opioid Induced Constipation Treatment Market Size by Type (2015-2020) (US$ Million) Table 47. Japan Opioid Induced Constipation Treatment Market Share by Type (2015-2020) Table 48. Japan Opioid Induced Constipation Treatment Market Size by Application (2015-2020) (US$ Million) Table 49. Japan Opioid Induced Constipation Treatment Market Share by Application (2015-2020) Table 50. Japan Opioid Induced Constipation Treatment Market Size by Country (US$ Million) (2015-2020) Table 51. Japan Opioid Induced Constipation Treatment Market Share by Country (2015-2020) Table 52. Southeast Asia Opioid Induced Constipation Treatment Market Size by Type (2015-2020) (US$ Million) Table 53. Southeast Asia Opioid Induced Constipation Treatment Market Share by Type (2015-2020) Table 54. Southeast Asia Opioid Induced Constipation Treatment Market Size by Application (2015-2020) (US$ Million) Table 55. Southeast Asia Opioid Induced Constipation Treatment Market Share by Application (2015-2020) Table 56. Southeast Asia Opioid Induced Constipation Treatment Market Size by Country (US$ Million) (2015-2020) Table 57. Southeast Asia Opioid Induced Constipation Treatment Market Share by Country (2015-2020) Table 58. GlaxoSmithKline Company Details Table 59. GlaxoSmithKline Business Overview Table 60. GlaxoSmithKline Product Table 61. GlaxoSmithKline Revenue in Opioid Induced Constipation Treatment Business (2015-2020) (US$ Million) Table 62. GlaxoSmithKline Recent Development Table 63. AstraZeneca Company Details Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Product Table 66. AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2015-2020) (US$ Million) Table 67. AstraZeneca Recent Development Table 68. Pfizer Company Details Table 69. Pfizer Business Overview Table 70. Pfizer Product Table 71. Pfizer Revenue in Opioid Induced Constipation Treatment Business (2015-2020) (US$ Million) Table 72. Pfizer Recent Development Table 73. S.L.A. Pharma Company Details Table 74. S.L.A. Pharma Business Overview Table 75. S.L.A. Pharma Product Table 76. S.L.A. Pharma Revenue in Opioid Induced Constipation Treatment Business (2015-2020) (US$ Million) Table 77. S.L.A. Pharma Recent Development Table 78. AIKO Biotechnology Company Details Table 79. AIKO Biotechnology Business Overview Table 80. AIKO Biotechnology Product Table 81. AIKO Biotechnology Revenue in Opioid Induced Constipation Treatment Business (2015-2020) (US$ Million) Table 82. AIKO Biotechnology Recent Development Table 83. Cubist Pharmaceuticals Company Details Table 84. Cubist Pharmaceuticals Business Overview Table 85. Cubist Pharmaceuticals Product Table 86. Cubist Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2015-2020) (US$ Million) Table 87. Cubist Pharmaceuticals Recent Development Table 88. Salix Pharmaceuticals Company Details Table 89. Salix Pharmaceuticals Business Overview Table 90. Salix Pharmaceuticals Product Table 91. Salix Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2015-2020) (US$ Million) Table 92. Salix Pharmaceuticals Recent Development Table 93. Takeda Pharmaceutical Business Overview Table 94. Takeda Pharmaceutical Product Table 95. Takeda Pharmaceutical Company Details Table 96. Takeda Pharmaceutical Revenue in Opioid Induced Constipation Treatment Business (2015-2020) (US$ Million) Table 97. Takeda Pharmaceutical Recent Development Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Global Opioid Induced Constipation Treatment Market Share by Type: 2020 VS 2026 Figure 2. Oral Features Figure 3. Parenteral (Subcutaneous Injection) Features Figure 4. Global Opioid Induced Constipation Treatment Market Share by Application: 2020 VS 2026 Figure 5. Drug Store Case Studies Figure 6. Independent Pharmacies Case Studies Figure 7. Hospital Pharmacies Case Studies Figure 8. Opioid Induced Constipation Treatment Report Years Considered Figure 9. Global Opioid Induced Constipation Treatment Market Size (US$ Million), YoY Growth 2015-2026 Figure 10. Global Opioid Induced Constipation Treatment Market Share by Regions: 2020 VS 2026 Figure 11. Global Opioid Induced Constipation Treatment Market Share by Regions (2021-2026) Figure 12. Global Opioid Induced Constipation Treatment Market Share by Players in 2019 Figure 13. Global Top Opioid Induced Constipation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation Treatment as of 2019 Figure 14. The Top 10 and 5 Players Market Share by Opioid Induced Constipation Treatment Revenue in 2019 Figure 15. North America Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 16. United States Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. Canada Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Europe Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Germany Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. France Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. U.K. Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Italy Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Russia Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Nordic Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Rest of Europe Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Asia-Pacific Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. China Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Japan Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. South Korea Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Southeast Asia Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. India Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Australia Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Rest of Asia-Pacific Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Latin America Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Mexico Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Brazil Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Middle East & Africa Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Turkey Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Saudi Arabia Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. UAE Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. GlaxoSmithKline Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2015-2020) Figure 43. AstraZeneca Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2015-2020) Figure 44. Pfizer Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2015-2020) Figure 45. S.L.A. Pharma Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2015-2020) Figure 46. AIKO Biotechnology Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2015-2020) Figure 47. Cubist Pharmaceuticals Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2015-2020) Figure 48. Salix Pharmaceuticals Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2015-2020) Figure 49. Takeda Pharmaceutical Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2015-2020) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

GlaxoSmithKline AstraZeneca Pfizer S.L.A. Pharma AIKO Biotechnology Cubist Pharmaceuticals Salix Pharmaceuticals Takeda Pharmaceutical